Correlation between variation in quality of life and change in hemoglobin level after treatment with epoetin alfa 40,000 IU administered once-weekly
Patrizia Beccaglia(Janssen (Italy)), Giorgio De Signoribus(Sapienza University of Rome), Giacomo Cartenì(Ospedale Antonio Cardarelli), Simona Orecchia(Janssen (Italy)), G. Ucci(Alessandro Manzoni Hospital), Laura Giannetta(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), A. Contillo(Ospedali Riuniti di Foggia), Graziella Pinotti(Medica (Italy)), Fabio Puglisi(University of Udine), Giuseppe Pezzella(Ospedale SS. Annunziata)
Cited by 12
Related Papers
Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer
|Journal of Clinical Oncology|2010|887
Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
|New England Journal of Medicine|2014|751
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
|New England Journal of Medicine|2018|684